Economic

Tariffs on Indian pharma would be counterproductive, ultimately burdening American consumers, says Pharmexcil Chairman Namit Joshi

Tariffs on Indian pharma would be counterproductive, ultimately burdening American consumers, says Pharmexcil Chairman Namit Joshi

Tariffs on Indian pharma would be counterproductive, ultimately burdening American consumers, says Pharmexcil Chairman Namit Joshi

Total tariffs on Indian products to touch 50% by month-end; MEA says action unfair, unjustified, unreasonable

We aim to make considerable investments in MRO capabilities, says Guruprasad Mysore of Honeywell India

Move to eliminate outdated colonial-era laws and align with global best practices to improve ease of doing business

HRS is a content-led platform for industry stakeholders across categories to come together to discuss current trends in the retail...

Addressing the 55th Convocation of Prof. Jayashankar Telangana State Agricultural University (PJTSAU) on Saturday, he said the country should increase...

Negotiations for India-US bilateral trade pact to continue despite tariff imposition on Aug 1

The firm’s AI platform guides farmers in growing plants and sell their produce to companies